Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.
9 Kesä 20min
Eli Lilly Isn’t Telling Us About Their Future Obesity Drugs
Does Eli Lilly already have the solve for obesity? In this episode of On the Pen — the Weekly Dose Podcast, host Dave Knapp breaks down a stunning comment from Lilly's Chief Scientific Officer Daniel ...
2 Kesä 20min
Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War
https://linktr.ee/manonthemounjaro
26 Touko 30min
Lilly Bets $8B on Weight Loss Future
https://linktr.ee/manonthemounjaro
19 Touko 23min
The Next Two Weeks in GLP1 Are Huge, Here's Why
http://www.otplinks.com
12 Touko 1h 7min
He Took Retatrutide 40mg and Proved a Point
This episode examines a serious case involving retatrutide, where an individual experienced an overdose due to improper medication administration. We discuss the critical importance of medication safe...
5 Touko 36min
Eli Lilly Earnings Call Recap: Q1 2026
We just got done listening to the quarter one, 2026 Eli Lilly earnings call. There was a lot of information to get into, whether you're interested in retatrutide, eloralintide, or Foundayo, and all of...
30 Huhti 25min
